On the “RFK, Jr. The Defender Podcast,” Dr. Peter McCullough discussed a new study by the Oxford University Clinical Research Group and how the Pfizer’s vaccine, at 17% to 42% efficacy, doesn't meet the regulatory standard of 50% efficacy for vaccines.
President Joe Biden hopes people will soon forget the unfolding disaster he created in Afghanistan so he can turn back to issues such as COVID, the economy, and climate change. But he and his White House don't realize just how damaging Afghanistan has been to the president’s credibility, undermining his ability to govern on every other issue.
As more celebrities and elected officials announce they are “really really sick” despite being fully vaccinated, questions swirl around whether the vaccines work and why the Centers of Disease Control and Prevention isn’t doing more to track breakthrough cases.
"It's one thing for somebody say that and keep pounding that in the head of your five granddaughters as well, but to, guess what, until they see it until they watch, it becomes real then."
Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.
U.S. drug regulators on Monday approved the COVID-19 vaccine from Pfizer and BioNTech for people 16 and older, making it the first such shot to receive approval in the country.
Houston hospitals have “reached a breaking point” amid a COVID-19 outbreak, which struck weeks after 150 hospital workers were fired by Houston Methodist hospital, one of several hospitals struggling.
Scientists opposed to offering booster shots to all Americans said data provided by federal health officials wasn’t compelling enough to support the recommendation — some argued boosters could lead to more vaccine-resistant variants.
Those who caught the Delta Variant of the CCP virus after being fully vaccinated carry a similar level of peak viral burden with their unvaccinated counterparts, a new UK analysis suggests.